IL-37 affects the occurrence and development of endometriosis by regulating the biological behavior of endometrial stromal cells through multiple signaling pathways
Author:
Jiang Jianfa1, Yu Kenan1, Jiang Zhaoying1, Xue Min1
Affiliation:
1. Department of Obstetrics and Gynecology , The Third Xiangya Hospital of Central South University, No. 138 tongzipo , Yuelu District, Changsha 100730, Hunan , China
Abstract
Abstract
Endometriosis (EMs) is a chronic inflammatory condition. Interleukin (IL)-37 is a member of the IL-1 family and an anti-inflammatory cytokine. This study aimed to evaluate the possible role of IL-37 in the EMs pathogenesis. We investigated the in vivo effect of IL-37 on EMs by injection with recombinant human IL-37 (rhIL-37) into EMs mice. Furthermore, we evaluated the in vitro effects of IL-37 on proliferation, adhesion, migration and invasiveness of endometrial stromal cells (ESCs), and explored whether Wnt/β-catenin and mitogen-activated protein kinase (MAPK) pathways were involved in this process. In cultured ESCs, IL-37 overexpression significantly suppressed both protein and mRNA expression of the inflammation-associated cytokines, including IL-1β, IL-6, IL-10 and tumor necrosis factor (TNF-α). Furthermore, IL-37 overexpression significantly inhibited ESCs proliferation, adhesion, migration, invasion and the activity of matrix metalloproteinase (MMP)-2 and MMP-9. In contrast, knockdown of IL-37 exerted the opposite effects. Importantly, the IL-37-mediated action in ESCs was through inactivation of Wnt/β-catenin, p38 MAPK, extracellular signal-related kinases MAPK and c-Jun N-terminal kinase MAPK pathways. Moreover, EMs mice treated with rhIL-37 showed the decreased endometriotic-like lesion size and lesion weight, lower expression of IL-1β, IL-6, IL-10, TNF-α, vascular endothelial growth factor (VEGF), soluble intercellular adhesion molecule-I (ICAM-I) and MMP-2/9 activity in peritoneal fluid compared with the wide type (WT) EMs mice. These findings suggest that IL-37 suppresses cell proliferation, adhesion, migration and invasion of human ESCs through multiple signaling pathways, thereby affecting the occurrence and development of EMs.
Publisher
Walter de Gruyter GmbH
Subject
Clinical Biochemistry,Molecular Biology,Biochemistry
Reference35 articles.
1. Altan, M., Bruner-Tran, K.L., Osteen, K.G., and Palmer, S. (2008). JNK inhibitor AS-01 causes regression of endometriosis and suppression of inflammatory cytokines and tissue remodeling enzymes. Biol. Reprod. 78, 168–169. 2. Ayala Yanez, R. and Mota Gonzalez, M. (2007). Endometriosis: physiopathology and investigation trends (first part). Ginecol. Obstet. Mex. 75, 477–483. 3. Ballak, D.B., van Diepen, J.A., Moschen, A.R., Jansen, H.J., Hijmans, A., Groenhof, G.J., Leenders, F., Bufler, P., Boekschoten, M.V., Muller, M., et al. (2014). IL-37 protects against obesity-induced inflammation and insulin resistance. Nat. Commun. 5, 4711. 4. Bersinger, N.A., Günthert, A.R., Mckinnon, B., Johann, S., and Mueller, M.D. (2011). Dose-response effect of interleukin (IL)-1β, tumour necrosis factor (TNF)-α, and interferon-γ on the in vitro production of epithelial neutrophil activating peptide-78 (ENA-78), IL-8, and IL-6 by human endometrial stromal cells. Arch. Gynecol. Obstet. 283, 1291–1296. 5. Beste, M.T., Pfaffle-Doyle, N., Prentice, E.A., Morris, S.N., Lauffenburger, D.A., Isaacson, K.B., and Griffith, L.G. (2014). Molecular network analysis of endometriosis reveals a role for c-Jun-regulated macrophage activation. Sci. Transl. Med. 6, 222ra216.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|